A significant reduction of beta-cell β1 integrin expression in the adult mouse resulted in impaired glucose tolerance and insulin secretion, reduced beta-cell mass, decreased signaling through the FAK/ERK and Akt pathways, and diminished beta-cell function and expansion. The gene discussed is AKT1; the disease is Impaired glucose tolerance.